Initial results of the iLSTA study: Effect of certepetide (LSTA‐1) combined with immunotherapy and chemotherapy for locally advanced pancreatic ductal adenocarcinoma (PDAC)
Asia-Pacific Journal of Clinical Oncology · 2026-11 · 22 (S6) · 16-16
DOI: 10.1111/ajco.70231 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, online erschienen am 19.11.2026.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Initial results of the iLSTA study: Effect of certepetide (LSTA‐1) combined with immunotherapy and chemotherapy for locally advanced pancreatic ductal adenocarcinoma (PDAC). Asia-Pacific Journal of Clinical Oncology, 22(S6), 16-16. https://doi.org/10.1111/ajco.70231
Vancouver
Initial results of the iLSTA study: Effect of certepetide (LSTA‐1) combined with immunotherapy and chemotherapy for locally advanced pancreatic ductal adenocarcinoma (PDAC). Asia-Pacific Journal of Clinical Oncology. 2026;22(S6):16-16. doi:10.1111/ajco.70231
BibTeX
@article{euvimed2026,
title = {Initial results of the iLSTA study: Effect of certepetide (LSTA‐1) combined with immunotherapy and chemotherapy for locally advanced pancreatic ductal adenocarcinoma (PDAC)},
journal = {Asia-Pacific Journal of Clinical Oncology},
year = {2026},
volume = {22},
number = {S6},
pages = {16--16},
doi = {10.1111/ajco.70231}
}
EUVIMED